TWINCORE

Since then, physicians and basic scientists from a wide range of disciplines have been working side by side in infection research here, in the immediate vicinity of the MHH campus. Our focus is on translational research - the interface between basic research and clinical development. 

Infectious diseases have been eradicated in many parts of the world. But they have not been defeated, quite the opposite: microbes are developing resistance to medicines, global trade and travel are carrying pathogens around the globe ever faster. Tuberculosis, AIDS, hepatitis and malaria threaten the health of many millions of people. The SARS-Cov-2 pandemic has made clear how great the threat posed by infectious agents still is today.

The latest results of basic research should lead to new therapies or diagnostic procedures for patients in a short way. At the same time, basic researchers are looking for answers to questions raised by clinical work. Another important component of this translational bridge that we build between research and practice are the approval procedures that must always be completed for clinical applications. At this point, our scientists at TWINCORE support the development of new strategies against infectious diseases by developing a scientific basis for risk assessment prior to clinical trials.